Research ArticleLaboratory Studies
The Processing and Fate of Antibodies and Their Radiolabels Bound to the Surface of Tumor Cells In Vitro: A Comparison of Nine Radiolabels
Lisa B. Shih, Suzanne R. Thorpe, Gary L. Griffiths, Habibe Diril, Gaik Lin Ong, Hans J. Hansen, David M. Goldenberg and M. Jules Mattes
Journal of Nuclear Medicine May 1994, 35 (5) 899-908;
Lisa B. Shih
Suzanne R. Thorpe
Gary L. Griffiths
Habibe Diril
Gaik Lin Ong
Hans J. Hansen
David M. Goldenberg


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
The Processing and Fate of Antibodies and Their Radiolabels Bound to the Surface of Tumor Cells In Vitro: A Comparison of Nine Radiolabels
Lisa B. Shih, Suzanne R. Thorpe, Gary L. Griffiths, Habibe Diril, Gaik Lin Ong, Hans J. Hansen, David M. Goldenberg, M. Jules Mattes
Journal of Nuclear Medicine May 1994, 35 (5) 899-908;
The Processing and Fate of Antibodies and Their Radiolabels Bound to the Surface of Tumor Cells In Vitro: A Comparison of Nine Radiolabels
Lisa B. Shih, Suzanne R. Thorpe, Gary L. Griffiths, Habibe Diril, Gaik Lin Ong, Hans J. Hansen, David M. Goldenberg, M. Jules Mattes
Journal of Nuclear Medicine May 1994, 35 (5) 899-908;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Mechanistically Weighted Metric to Predict In Vivo Antibody-Receptor Occupancy: An Analytical Approach
- Approaches to Improve the Pharmacokinetics of Radiolabeled Glucagon-Like Peptide-1 Receptor Ligands Using Antagonistic Tracers
- 89Zr-Labeled Versus 124I-Labeled {alpha}HER2 Fab with Optimized Plasma Half-Life for High-Contrast Tumor Imaging In Vivo
- Applying PET to Broaden the Diagnostic Utility of the Clinically Validated CA19.9 Serum Biomarker for Oncology
- Effect of Small-Molecule-Binding Affinity on Tumor Uptake In Vivo: A Systematic Study Using a Pretargeted Bispecific Antibody
- Assessing Antibody Pharmacokinetics in Mice with In Vivo Imaging
- Influence of Affinity and Antigen Internalization on the Uptake and Penetration of Anti-HER2 Antibodies in Solid Tumors
- Small-Animal PET of Melanocortin 1 Receptor Expression Using a 18F-Labeled {alpha}-Melanocyte-Stimulating Hormone Analog
- 111In-Benzyl-DTPA-ZHER2:342, an Affibody-Based Conjugate for In Vivo Imaging of HER2 Expression in Malignant Tumors
- In vitro cytotoxicity of carcinoma cells with 111In-labeled antibodies to HER-2
- Therapy of Small Subcutaneous B-Lymphoma Xenografts with Antibodies Conjugated to Radionuclides Emitting Low-Energy Electrons
- In vitro Toxicity of A-431 Carcinoma Cells with Antibodies to Epidermal Growth Factor Receptor and Epithelial Glycoprotein-1 Conjugated to Radionuclides Emitting Low-Energy Electrons
- Biodistribution and Therapeutic Efficacy of 125/131I-, 186Re-, 88/90Y-, or 177Lu-Labeled Monoclonal Antibody MN-14 to Carcinoembryonic Antigen in Mice with Small Peritoneal Metastases of Colorectal Origin
- Radioiodination of Rhenium Cyclized {alpha}-Melanocyte-Stimulating Hormone Resulting in Enhanced Radioactivity Localization and Retention in Melanoma
- Optimization of Radioimmunotherapy of Renal Cell Carcinoma: Labeling of Monoclonal Antibody cG250 with 131I, 90Y, 177Lu, or 186Re
- Targeting of Metastatic Renal Cell Carcinoma with the Chimeric Monoclonal Antibody G250 Labeled with 131I or 111In: An Intrapatient Comparison
- Pretargeting with Labeled Bivalent Peptides Allowing the Use of Four Radionuclides: 111In, 131I, 99mTc, and 188Re
- A Comparison of 4 Radionuclides Conjugated to Antibodies for Single-Cell Kill
- Improved Iodine Radiolabels for Monoclonal Antibody Therapy
- Intracellular Accumulation of the Anti-CD20 Antibody 1F5 in B-Lymphoma Cells
- Antibody Localization to B-Cell Lymphoma Xenografts in Immunodeficient Mice: Importance of Using Residualizing Radiolabels
- Therapeutic Advantage of 90Yttrium- versus131Iodine-labeled PAM4 Antibody in Experimental Pancreatic Cancer
- Comparative Cellular Catabolism and Retention of Astatine-, Bismuth-, and Lead-Radiolabeled Internalizing Monoclonal Antibody
- Specific Targeting, Biodistribution, and Lack of Immunogenicity of Chimeric Anti-GD3 Monoclonal Antibody KM871 in Patients With Metastatic Melanoma: Results of a Phase I Trial
- Metabolite Production in Patients with Lymphoma After Radiometal-Labeled Antibody Administration
- Radioimmunotherapy of a Human Lung Cancer Xenograft with Monoclonal Antibody RS7: Evaluation of 177Lu and Comparison of Its Efficacy with That of 90Y and Residualizing 131I
- Therapy of Disseminated B-Cell Lymphoma Xenografts in Severe Combined Immunodeficient Mice with an Anti-CD74 Antibody Conjugated with 111Indium, 67Gallium, or 90Yttrium
- Optimal Quality 131I-Monoclonal Antibodies on High-Dose Labeling in a Large Reaction Volume and Temporarily Coating the Antibody with IODO-GEN
- Single-cell Cytotoxicity with Radiolabeled Antibodies
- Radionuclides Linked to a CD74 Antibody as Therapeutic Agents for B-Cell Lymphoma: Comparison of Auger Electron Emitters with {beta}-Particle Emitters
- In Vivo Biodistribution of a Humanized Anti-Lewis Y Monoclonal Antibody (hu3S193) in MCF-7 Xenografted BALB/c Nude Mice
- Effects of Colloidal Resuscitation Fluids on Reticuloendothelial Function and Resistance to Infection after Hemorrhage